Skip to content

Stem cells

Coming soon

Stem cells, under careful review.

Everdawn is evaluating a future clinician-led cellular medicine program, and will publish details only after clinical, regulatory and partner review.

A direction, not a treatment offer.

Details will be published only after the exact clinical model, regulatory pathway, qualified partners, locations, eligibility and patient safeguards are in place and approved.

  • Still in development

    No launch date, product, procedure or method is promised.

  • Review comes first

    Any future offering must complete clinical, regulatory, legal and partner review.

  • Clinician-led if launched

    Any future medical decision would stay with a licensed clinician.

  • Clear status

    Available care is always kept separate from future ideas.

What FDA says today.

  • Cord blood

    Blood-forming stem cells from umbilical cord blood are the only FDA-approved stem-cell products, for disorders that affect blood production.1

  • None

    FDA states there are no FDA-approved exosome products.1

Registration, or treatment in an inspected lab, does not mean a treatment is approved. Ask for the exact product, its status and the evidence.

What to know today.

Can I buy or enroll in stem-cell treatment now?

No. Everdawn does not offer a stem-cell product, procedure, prescription or treatment through this site.

What exact treatment is coming?

The future program has not been finalized. Everdawn will not announce a product, method, location, eligibility criteria or launch date until the complete model has been reviewed and approved.

Does this page promise eligibility or results?

No. This page is an early notice about a future area of care. It does not promise availability, eligibility, safety, effectiveness or any particular outcome.

Hear when this program opens.

Ask about this program and we’ll let you know when there is news. Please don’t include health details in your message.

Coming soon. Nothing on this page can be ordered, and no clinical relationship is created by asking.

Sources

  1. FDA: Consumer alert on regenerative medicine products